examine in parallel a sufficiently large set of cell lines. We derived a set of iPSC lines that includes many sources of variation that might be encountered in the course of modeling development or disease, including age, sex, health status and donor identity. We then compared the ability of the lines to undergo directed differentiation as a stringent test of their pluripotency. We selected motor neurons as a model system because they are an example of the many differentiated human cell types that cannot be obtained by other means, and are specifically affected in amyotrophic lateral sclerosis (ALS) 10 .
After all cell lines were extensively characterized, we found that, like ESCs, most iPSCs were capable of generating functional motor neurons under a standard differentiation protocol, whereas a few lines required more efficient neuralization. The efficiency with which each individual line generated motor neurons was highly reproducible between two different laboratories, indicating that the collection can function robustly as a shared resource. Potential sources of variation between iPSC lines, such as donor age and transgene expression, did not correlate with differentiation efficiency. Likewise, no significant differences were found between three-factor and four-factor lines, or between lines from healthy and ALS patients. However, we found that two parameters may be associated with differing behavior of lines. Donor identity and donor sex were both associated with variation in Reprogramming of somatic cells to iPSCs presents an opportunity to produce previously inaccessible cell types for disease-related studies 1 . IPSCs can be made from patients and their healthy relatives, allowing the genetic variants that either predisposed them to or protected them from disease to be studied [2] [3] [4] [5] . However, if patient-specific iPSCs are to become a standard resource, it is vital to understand how reliably they generate differentiated derivatives. Among the concerns raised about iPSCs is that reprogramming may be incomplete, resulting in cell lines with variable gene expression or DNA methylation [6] [7] [8] . Indeed, it was reported that when human iPSC lines were differentiated toward a motor neuron identity, they uniformly failed to produce this neural subtype with the efficiency observed using ESCs 9 . Moreover, it has been suggested that differentiated progeny of iPSCs that harbor reprogramming proviruses have a problematic gene expression signature that can be resolved only by viral excision 5 . Another open question is whether standard reprogramming, expansion and directed differentiation processes are robust enough to minimize noise caused by donor-to-donor variation, which could obscure disease-specific phenotypes. Finally, it has not been determined whether individual iPSC lines behave similarly from laboratory to laboratory.
To address these questions and to determine whether cell-line variability might limit the utility of iPSCs, it is necessary to systematically Human induced pluripotent stem cells (iPSCs) present exciting opportunities for studying development and for in vitro disease modeling. However, reported variability in the behavior of iPSCs has called their utility into question. We established a test set of 16 iPSC lines from seven individuals of varying age, sex and health status, and extensively characterized the lines with respect to pluripotency and the ability to terminally differentiate. Under standardized procedures in two independent laboratories, 13 of the iPSC lines gave rise to functional motor neurons with a range of efficiencies similar to that of human embryonic stem cells (ESCs). Although three iPSC lines were resistant to neural differentiation, early neuralization rescued their performance. Therefore, all 16 iPSC lines passed a stringent test of differentiation capacity despite variations in karyotype and in the expression of early pluripotency markers and transgenes. This iPSC and ESC test set is a robust resource for those interested in the basic biology of stem cells and their applications.
compact colonies with a morphology (Fig. 1a and Supplementary  Fig. 1a ) and cell-cycle profile similar to those of ESC controls ( Fig. 1b and Supplementary Fig. 1b) . We next determined that the test set could differentiate into all three embryonic germ layers as detected by expression of neuron-specific tubulin (TUJ1), smooth muscle actin (αSMA) and endodermal α-fetoprotein (AFP) after 16 d of differentiation in vitro ( Fig. 1c and Supplementary Fig. 1c ). Lastly, we tested the ability of several lines to generate teratomas in immune-compromised mice. After injection, each line (14/14 tested) formed teratomas containing complex tissue structures characteristic of all three embryonic germ layers ( Fig. 1d and Supplementary  Fig. 1d ). Based on histological criteria these structures included neuronal fibers, hair follicles, melanocytes, keratin pearls, muscle cells, cartilage, glands and goblet cells. Thus our test set resource contains lines that have been extensively characterized and meet the most stringent criteria for pluripotency (Fig. 1e) .
Most iPSC lines generate electrically active motor neurons using standard procedures To rigorously and quantitatively test the potential of iPSCs to undergo terminal differentiation, we determined the efficiency with which each line could generate spinal motor neurons (Fig. 2) . In response to standard procedures involving retinoic acid and induction of the sonic hedgehog pathway 12, 13 (Fig. 2a) , the majority (19/22) of the iPSC and ESC lines generated cells with a neuronal morphology that expressed TUJ1 and the motor neuron marker ISLET 1/2 (ISL) (Fig. 2b) . To confirm the reliability of the lines as a resource for the community, we transferred the entire test set from the laboratory in which they were derived (Eggan laboratory) to a geographically distinct laboratory (Project A.L.S. (PALS)/Jenifer Estess Laboratory for Stem Cell Research, Columbia University), which then repeated differentiation performance and warrant further study. The test set reported here has already served as the basis for an analysis of the epigenetic influences on stem cell differentiation potential 11 . The test set cell lines are available for distribution and should prove to be a valuable resource for many avenues of stem cell research.
RESULTS

A test set of iPSC lines
We assembled a test set of 16 human iPSC lines, including 14 new lines and 2 previously reported lines 2 ( Table 1) . This set comprised lines from seven individuals of both sexes whose ages ranged from 29 to 82 years. All iPSCs were derived by retroviral transduction of skin fibroblasts. Most lines were produced using only three factors (OCT4, KLF4, SOX2) but two lines derived using the additional factor c-MYC 2 were included for comparison.. To allow evaluation of the effects of individual genetic background, we included independent lines derived from the same subjects (two lines from each of two donors, three lines from each of two donors and four lines from one donor). Finally, we included lines from both healthy controls (n = 10) and patients with ALS (n = 6), all of which carried mutations in the superoxide dismutase 1 gene (SOD1). To determine whether reprogramming systematically influences stem cell properties, we compared the performance of these iPSC lines to that of six ESC lines ( Table 1) .
To verify that the newly derived iPSC lines were indeed pluripotent stem cells, we assessed expression of the pluripotency markers alkaline phosphatase, NANOG, OCT4, SSEA3, SSEA4, TRA-1-60 and TRA-1-81. In addition to exhibiting cell-surface staining patterns for both SSEA and TRA-1 proteins, all colonies showed distinct nuclear staining when assayed for NANOG and OCT4 immunoreactivity ( Fig. 1a and Supplementary Fig. 1a ). All iPSC lines generated 
Sixteen human iPSC lines were used for comparison with each other and with six ESC lines. IPSC lines include 14 newly generated three-factor lines from two ALS patients and five controls, and two previously published four-factor lines from one ALS patient. This cohort of human stem cell lines allows comparisons to be made between ESCs and iPSCs, between three-factor and four-factor iPSC lines, between male and female lines, between lines derived from the same donor and those derived from another donor, and between cells derived from ALS patients and control donors.
( Fig. 2f and Supplementary To demonstrate that the motor neurons we produced were functional, we compared the electrophysiological properties of motor neurons from four iPSC lines with motor neurons from two ESC lines (Fig. 3) . We first monitored intracellular Ca 2+ dynamics using the Ca 2+ -sensitive dyes Fura Red AM (Fig. 3a-b) and Fluo-4 AM (Fig. 3c) . This was done both in the absence of exogenous stimulation (Fig. 3c,h,j) to monitor spontaneous activity, and after application of either kainate to activate ionotropic glutamate receptors, or KCl to depolarize the membrane and open voltage-gated Ca 2+ channels ( Fig. 3d-g,i,k) . Spontaneous calcium transients were visible in the cell the directed differentiation experiments. Consistent with the conclusion that the properties of each cell line are reproducible, the same lines were found to generate ISL + neurons (Fig. 2c) . Indeed, the differentiation efficiency for each line (ranging from 4-15% ISL + /total nuclei) showed no difference between the two laboratories ( Fig. 2c ; ANOVA f = 1.132, P = 0.301, Supplementary Table 1) . Thus, the test set will also serve as a robust resource for research in other centers.
To confirm that the ISL + neurons were motor neurons, we quantified the expression of other markers indicative of this neural subtype. We found that the iPSC lines producing the highest percentage of ISL + neurons also produced the highest percentage of cells expressing the motor neuron-specific transcription factor HB9 (ref. 14; Fig. 2d ). On average, iPSC lines generated HB9 + neurons as efficiently as did the established ESC line HuES-13 ( Fig. 2h) . In addition, in a tested subset of lines, ISL + neurons were immunopositive for ChAT, the enzyme required for acetylcholine synthesis (Fig. 2e) . These differentiated cultures, which also contained a variety of motor neuron progenitors, expressed the neural marker NCAM ( Supplementary Fig. 2a) , and expressed substantial levels of mRNA encoding the markers HB9, ChAT and CHT1 ( Supplementary Fig. 2b ). Finally, unlike PAX6 + progenitors in these cultures, ISL + neurons were never observed to be actively cycling as measured by Ki67 immunostaining ( Supplementary Fig. 2c ). Although there were quantitative differences in motor neuron generation among the lines ( Fig. 2i stimuli in current-clamp mode elicited single action potentials in both ESC-derived (n = 2) and iPSC-derived neurons (n = 2), as well as repetitive firing in a neuron derived from iPSC line 18a (Fig. 3o) . Therefore, we conclude that both ESC-and iPSC-derived neurons generated from the cell lines in the resource are similarly functional at a physiological level.
Contribution of other variables to differentiation
Although all cell lines were capable of generating motor neurons, we systematically examined some parameters that have been implicated in differentiation efficiency and so would be of interest to potential users of this resource. The majority of iPSC lines (9 out of 15 tested; Supplementary Fig. 4 ) exhibited genomic stability at both early (p13) and late (p42) passages. The other six lines (29d, 27b, 29e, 11a, 11b, 15b) acquired disparate abnormalities of varying severity at later passages. However, lines that became karyotypically abnormal did not produce motor neurons with a significantly different efficiency compared with normal lines (P = 0.932; Supplementary Table 1) .
bodies and processes of multiple cells from each line, even without treatment (Fig. 3c,h,j; Supplementary Fig. 3a and Supplementary Video 1). Upon exposure to kainate, increases in Ca 2+ levels were observed in 78% of cells with neuronal morphology (n = 132 cells). Many kainate-responsive cells also exhibited Ca 2+ transients upon exposure to KCl (Fig. 3i,k) . Immunostaining confirmed that many of the cells that responded to kainate and KCl in these mixed cultures were ISL + motor neurons (Fig. 3b,i and Supplementary Fig. 3b ).
To further demonstrate that iPSC-derived neurons express the repertoire of voltage-gated ion channels characteristic of active neurons, we made electrophysiological recordings using whole-cell patch clamping. All cells with a neuronal morphology, derived from HuES-3 hb9:GFP (n = 9 cells), iPSC line 18a (n = 10 cells) and iPSC line 27b (n = 10 cells), showed fast voltage-activated inward currents followed by slow outward currents, consistent with voltage-activated sodium and potassium currents, respectively (Fig. 3l,m) . Inward currents (n = 5/5) were blocked by tetrodotoxin (TTX), an inhibitor of voltage-gated sodium channels (Fig. 3n) . In addition, depolarizing Hu9  29e  29d  29b  29a  27e  27b  20b  18c  18b  18a  17b  17a  15b  11c  11b Hu3-hb9 GFP by the percentage of ISL + neurons (R 2 = 0.1687). In addition, we carried out immunofluorescence staining for OCT4 and the motor neuron marker ISL ( Fig. 4b and Supplementary Fig. 5e ). Remarkably, a line such as 15b, which showed persistent transgene expression, generated motor neurons with high abundance, even though many of the motor neurons expressed nuclear OCT4. Therefore, although examples of lines that display karyotypic variation and persistent transgene expression are available in the test set, these phenomena had no detectable effect on rates of motor neuron differentiation. Finally, we looked at the contribution of age, sex and donor genotype to the outcome of differentiation in our test set. There was no correlation between donor age and the percentage of ISL + neurons generated (R 2 = 0.0084). However, there was a significant difference in differentiation efficiency between male and female lines (ANOVA P = 0.048, Supplementary Table 3 ). These sex-specific differences could result from variable processes such as X-chromosome inactivation. Lastly, we compared the ability of independent lines from several of the donors to differentiate into motor neurons. Southern blot analysis ( Supplementary Fig. 6a-c) confirmed that lines from donors 11, 18 and 29 arose from distinct reprogramming events. Subsequently, As it is not known how these chromosomal changes may affect the behavior of any given cell type, these lines should be used with caution in studies making phenotypic comparisons.
We and others have reported that reprogramming transgenes can continue to be expressed in patient-specific iPSC lines, but whether they interfere with differentiation has not been fully studied 2, 5 . We therefore used quantitative real time (qRT)-PCR to quantify relative levels of transcription of the reprogramming transgenes from both their endogenous loci and from the integrated retrovirus (Fig. 4a) . In most cases, levels of viral transcription were either undetectable or very low compared with levels of transcripts from the endogenous loci; indeed, viral SOX2 was never detected (Supplementary  Fig. 5a). However, a subset of iPSC lines (11b, 11c, 15b, 18b, 18c , 27b, 27e and 29e) continued to express varying levels of viral KLF4 both in the undifferentiated state and after differentiation to motor neurons ( Fig. 4a and Supplementary Fig. 5b-d) . Moreover, viral OCT4 transcripts were present in three of the iPSC lines (15b, 18c and 27b) both before and after differentiation. Notably, there was no correlation between the total level of aggregated transgene expression in iPSCs and the efficiency of motor neuron differentiation as judged phology but less than 10% of differentiated cells were TUJ1 + neurons (Fig. 5b) . This was significantly lower compared with 18a (Holm-Sidak, T = 5.037, P = 0.002; Supplementary Table 6) , and was in contrast to the results of lines that differentiated appropriately, which produced in excess of 25% TUJ1 + cells (Supplementary Fig. 7b ). An indication that early blockade of differentiation might occur in some lines was obtained when we used expression of the antigens SSEA3 and TRA-1-60 to quantify the relative proportion of pluripotent cells within each iPSC line by flow cytometry (Supplementary Fig. 8) . One of the recalcitrant iPSC lines (27e) showed higher median fluorescence intensity of TRA-1-60 staining than all others (Supplementary Fig. 8d,e and Supplementary Table 7) , suggesting that it might be less prone to spontaneous differentiation. As the three recalcitrant lines were nevertheless able to initially form embryoid bodies, we tested whether they could be coaxed into the motor neuron differentiation pathway by pushing them toward a more neural fate at the beginning of the differentiation process. We combined our embryoid body protocol with dual SMAD inhibition, similar to a previous report 15 , for the first 9 d using SB431542, an inhibitor of transforming growth factor-β1 activin receptor-like kinase, and LDN193189, a structural analog of the bone morphogenetic protein inhibitor dorsomorphin 15, 16 . Comparing the three underperforming iPSC lines (11b, 27e, 29e) to two ESC lines, we found that the previously defective lines were all neuralized in this optimized protocol and gave rise to the same high abundance of TUJ1 + cells as did the ESC lines (>75%; Fig. 5c,d) . Notably, the three iPSC lines that previously could not generate neurons now robustly produced ISL + (Fig. 5c,e ) and HB9 + (Fig. 5f ) motor neurons by day 21 at levels indistinguishable from those of both the control ESCs (Fig. 5d-f ) and the other 13 iPSC lines (Fig. 2h,i) . Thus, although three lines in our human stem cell resource underperformed using a basal differentiation protocol, they could be rescued through a neuralizing protocol to efficiently generate spinal motor neurons.
DISCUSSION
To evaluate iPSCs as a research tool, we generated a large panel of cell lines from multiple donors and examined aspects of the cell lines' pluripotency and ability to generate terminally differentiated motor neurons. The results of our comparisons confirm the remarkable value of iPSC lines for in vitro studies and demonstrate that they can perform as well as standard ESC lines. This observation held true for experiments carried out using standardized procedures in two geographically distinct laboratories. The analyses presented here serve as a quality control for this stem cell resource, while also providing sufficient data on specific aspects of variability to allow investigators to select lines of particular relevance to their research. Our study is not the first to compare human iPSC and ESC lines, but it is the most extensive comparison of their ability to generate a specific terminally differentiated cell thus far. Most studies have used panels of four or fewer iPSC lines [17] [18] [19] [20] [21] [22] , limiting the inspection of the differentiation data (Fig. 2c,h,i) showed that all three iPSC lines from donor 18 produced many motor neurons, whereas the lines from donor 11 performed less well. The difference in differentiation efficiency between line 18c, the best of the three from that donor, and the two lines from donor 11 that generated motor neurons was indeed significant (P < 0.05; Fig. 2i ; Supplementary Table 2) , and when comparisons between averaged differentiation efficiencies of multiple lines from each donor were made, a significant difference was found (ANOVA P = 0.006; Supplementary Table 4 and Supplementary Fig. 6d) . These results further demonstrate that the cell lines included in the test set may provide an opportunity for other researchers to investigate the effects that sex and other donor-specific phenomenon have in directed differentiation.
Suboptimal lines are rescued by active neuralization
Although the majority of our cell lines reproducibly generated motor neurons, there were three lines (11b, 27e and 29e) that uniformly failed to do so in both laboratories. All three formed embryoid bodies (Fig. 5a , n = 3-7 independent experiments per line), but the embryoid bodies from two lines-27e and 29e-became cystic and disaggregated (Fig. 5a) . This defect was reflected in a significant decrease in total yield of differentiated cells (P < 0.05; Supplementary Fig. 7a and Supplementary Table 5 ) and by the failure of these two lines to generate TUJ1 + neurons ( Supplementary  Fig. 7b) . A third line-11b-formed embryoid bodies with normal mor- 27e  20b  18c  18b  18a  17b  11a  17a  15b  11c  11b  2 9e HuES FB  11a  H uAvg  29d  27b  20b  18c  18b  18a  17b  17a  15b  11b HuES FB avg. avg. avg. avg.   11a  2 9d  27e  20b  18c  18b  18a  17b  11a  17a  15b  11c  11b  2 9e HuES FB  11a  H uAvg  29d  27b  20b  18c  18b  18a  17b  17a  15b that, once ALS-related phenotypic differences are discovered, they will prove sufficiently reproducible to serve as a foundation for research on ALS.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturebiotechnology/. 9 , we found that the differentiation efficiencies of individual iPSC lines vary. However, the earlier study showed that the differentiation capacity of iPSCs was inferior to that of ESCs, whereas we found that iPSC lines could be made to differentiate on average as well as ESC lines.
Whether the difference in the conclusions of the two studies is due to differences in the protocols for reprogramming and motor neuron differentiation, or whether it reflects differences in the numbers of samples analyzed, remains to be determined. Although all cell lines in our test set were capable of generating motor neurons, application of the standard protocol for motor neuron production did reveal significant quantitative differences in the propensity of the lines for terminal differentiation. These differences were highly reproducible, suggesting that they represent intrinsic characteristics of the lines. Our initial hypothesis was that the poorly performing lines would be identified by anomalies in standard tests for stem cell quality. However, all cell lines tested expressed pluripotency markers and could form the three germ layers in vitro and in teratomas. Moreover, although variations in karyotype and transgene expression were observed, they were not accurate predictors of differentiation capacity. Fortunately, a solution for identifying such predictors has now been proposed by a laboratory that used our test set to search for epigenetic and transcriptional differences that correlate with differentiation potential 11 . Using the lines we describe here, they developed a scorecard for stem cell quality that predicted our motor neuron differentiation results (Fig. 2i) with remarkable precision.
We anticipate that one of the major uses of the cell lines provided through this resource will be to model ALS. Notably, our data demonstrate that several conditions that are necessary for reliable disease modeling are met. First, because ALS is not a developmental disease, our finding that iPSCs carrying an ALS-triggering mutation differentiated similarly to those from healthy controls is as expected. Second, although lines from different healthy donors, taken together, showed donor-related variation in differentiation efficiency, the pairwise comparisons did not reach significance. This increases the chances that phenotypic differences we may eventually observe between ALS cases and controls are related to disease. Nevertheless, as we found real line-to-line differences, it will be essential to confirm that any phenotypes are ALS-related by silencing the mutant SOD1. Lastly, the strong concordance between the results from two different laboratories reported here suggests 
